We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-16.56%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.3B
AUM Growth
-$2.37B
(-6.3%)
Cap. Flow
+$5.08B
Cap. Flow
% of AUM
14.42%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
3,021
New
306
Increased
1,176
Reduced
1,104
Closed
398
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$410M |
| 2 |
Snap
SNAP
|
+$321M |
| 3 |
Altria Group
MO
|
+$312M |
| 4 |
Meta Platforms (Facebook)
META
|
+$295M |
| 5 |
Intel
INTC
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$283M |
| 3 |
S&P Global
SPGI
|
+$251M |
| 4 |
Amazon
AMZN
|
+$221M |
| 5 |
Eli Lilly
LLY
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Healthcare | 18.6% |
| 3 | Financials | 10.47% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Discretionary | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Bio-Rad Laboratories Class A
BIO
$8.42B
| $22.4M | 0.06% |
45,168
+9,800
| +28% | +$5.1M |
|
302
Tandem Diabetes Care
TNDM
$1.17B
| $22.2M | 0.06% |
375,883
+346,390
| +1,174% | +$28.4M |
|
303
Sabre
SABR
$656M
| $22.2M | 0.06% |
3,810,600
-176,700
| -4% | -$1.48M |
|
304
Rockwell Automation
ROK
$51.4B
| $22.2M | 0.06% |
+111,300
| New | +$25.1M |
|
305
BioCryst Pharmaceuticals
BCRX
$2.37B
| $22M | 0.06% |
2,083,412
+312,400
| +18% | +$3.22M |
|
306
Roblox
RBLX
$34B
| $22M | 0.06% |
668,900
+448,100
| +203% | +$15.1M |
|
307
Jackson Financial
JXN
$8.32B
| $21.9M | 0.06% |
819,600
-79,600
| -9% | -$2.9M |
|
308
Upwork
UPWK
$1.09B
| $21.9M | 0.06% |
1,058,500
-71,800
| -6% | -$1.41M |
|
309
NVIDIA
NVDA
$5.01T
| $21.7M | 0.06% |
1,429,000
-1,719,000
| -55% | -$32.4M |
|
310
Star Bulk Carriers
SBLK
$3.14B
| $21.6M | 0.06% |
864,340
+87,500
| +11% | +$2.54M |
|
311
BioMarin Pharmaceuticals
BMRN
$11.5B
| $21.3M | 0.06% |
256,914
+27,800
| +12% | +$2.21M |
|
|
DVAX
312
DELISTED
Dynavax Technologies
DVAX
| $21.2M | 0.06% |
1,682,288
-38,400
| -2% | -$408K |
|
313
Qiagen
QGEN
$8.53B
| $21.1M | 0.06% |
422,422
+209,736
| +99% | +$10.2M |
|
314
IDEX
IEX
$16.5B
| $21.1M | 0.06% |
116,300
+46,100
| +66% | +$8.69M |
|
315
Amdocs
DOX
$5.53B
| $21M | 0.06% |
251,900
-129,000
| -34% | -$10.6M |
|
316
SM Energy
SM
$7.96B
| $21M | 0.06% |
613,202
-117,700
| -16% | -$4.78M |
|
317
Radian Group
RDN
$5.14B
| $20.9M | 0.06% |
1,063,248
-376,800
| -26% | -$7.92M |
|
318
Sarepta Therapeutics
SRPT
$1.66B
| $20.9M | 0.06% |
278,434
-60,900
| -18% | -$4.48M |
|
319
American Electric Power
AEP
$73.7B
| $20.8M | 0.06% |
217,300
+165,300
| +318% | +$16.4M |
|
320
Autohome
ATHM
$2.43B
| $20.8M | 0.06% |
528,600
-180,800
| -25% | -$5.63M |
|
321
Toll Brothers
TOL
$14B
| $20.7M | 0.06% |
464,200
-22,700
| -5% | -$1.06M |
|
322
Healthcare Realty
HR
$7.42B
| $20.6M | 0.06% |
739,400
+295,500
| +67% | +$8.78M |
|
323
Corpay
CPAY
$24.2B
| $20.6M | 0.06% |
97,920
-106,000
| -52% | -$25.2M |
|
324
iShares S&P 500 Growth ETF
IVW
$72.5B
| $20.4M | 0.06% |
338,500
+72,900
| +27% | +$4.82M |
|
325
Ralph Lauren
RL
$22.2B
| $20.4M | 0.06% |
227,389
+23,900
| +12% | +$2.41M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Two Sigma Advisers held 3,021 positions worth $35.3B, down 6.3% from $37.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $5.08B of net new capital in Q2 2022, opening 306 new positions and adding to 1,176 existing holdings. Its largest new stake was Snap: 14,064,077 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $283M trimmed.
- Two Sigma Advisers's largest Q2 2022 buy was Snap: 14,064,077 shares worth $185M.
- Two Sigma Advisers added most to Netflix in Q2 2022, an estimated $410M increase.
- Two Sigma Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $283M.
- Two Sigma Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $407M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $35.3B portfolio in Q2 2022.
- Two Sigma Advisers opened 306 new positions and closed 398 in Q2 2022.
- Two Sigma Advisers's portfolio value fell 6.3% quarter-over-quarter to $35.3B.
Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.